The USPTO requested that Myriad restrict its application to one invention, and suggested
ways to group claims in distinct inventions; Myriad responded with alternate combinations
of claims into fewer new distinct inventions.
United States Patent and Trade Office; & Myriad Genetics, Inc. (1997). USPTO Office Action, and Myriad Genetics' Subsequent Response. Retrieved from http://hdl.handle.net/10161/7674.
